Ricin Vaccine Shows Positive Phase 1B Clinical Trial Results
Soligenix last week announced the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of ...
Soligenix last week announced the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of ...
The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Proposals (RFP) for anthrax antitoxin products to ...
US Army Medical Research Institute of Chemical Defense (USAMRICD) has issued an intent to award a sole source contract to ...
The Biological Advanced Research and Development Authority (BARDA) has confirmed a July 16, 2012 Pre-Proposal Conference in Washington D.C. to ...
The Department of Health and Human Services (HHS) this week awarded major contracts to establish three new “Centers for Innovation ...
The Biomedical Advanced Research and Development Authority (BARDA) has formally released BARDA-CBRN-BAA-12-100-SOL-00011 for “Advanced Research and Development of Chemical, Biological, Radiological, ...
Last week a Delaware Court of Chancery issued its final judgment in litigation spanning over 5 years brought by PharmAthene, ...
Australian drug development company Biota announced on Monday that it will be moving to the United States and merging with ...
Making anthrax treatment kits available to millions of households in the U.S. is not prudent because it could lead to misuse of ...
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) issued a ...
The Biomedical Advanced Research and Development Authority (BARDA), under the Department of Health and Human Services (HSS), has extended the ...
The U.S. Senate unanimously approved reauthorization of the Pandemic and All-Hazards Preparedness Act of 2006 (PAHPA, S. 1855) on March ...
Biomedical Advanced Research and Development Authority (BARDA) will release a new Broad Agency Announcment (BAA) on 4 March, 2012 for ...
CUBRC, Inc. and Tetraphase Pharmaceuticals have been awarded a contract for the advanced development of an antibiotic (TP-434) that could ...